192 related articles for article (PubMed ID: 24002436)
21. [Morphology and microRNA expression profiles of drug-resistant cells in hepatocellular carcinoma].
Zhuo LJ; Chen H; Wu MX; Gao MQ; Chen SP; Huang AM
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):604-8. PubMed ID: 24314246
[TBL] [Abstract][Full Text] [Related]
22. MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells.
Yang T; Zheng ZM; Li XN; Li ZF; Wang Y; Geng YF; Bai L; Zhang XB
Exp Biol Med (Maywood); 2013 Sep; 238(9):1024-32. PubMed ID: 23925649
[TBL] [Abstract][Full Text] [Related]
23. miR-122 affects the viability and apoptosis of hepatocellular carcinoma cells.
Wu X; Wu S; Tong L; Luan T; Lin L; Lu S; Zhao W; Ma Q; Liu H; Zhong Z
Scand J Gastroenterol; 2009; 44(11):1332-9. PubMed ID: 19891584
[TBL] [Abstract][Full Text] [Related]
24. Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431.
Geng S; Wang Q; Wang J; Hu Z; Liu C; Qiu J; Zeng W
Arch Dermatol Res; 2011 Apr; 303(3):181-9. PubMed ID: 21240514
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the genome-wide DNA methylation profile of side population cells in hepatocellular carcinoma.
Zhai JM; Yin XY; Hou X; Hao XY; Cai JP; Liang LJ; Zhang LJ
Dig Dis Sci; 2013 Jul; 58(7):1934-47. PubMed ID: 23625283
[TBL] [Abstract][Full Text] [Related]
26. Identification of cancer stem cell-related microRNAs in hepatocellular carcinoma.
Ji J; Wang XW
Methods Mol Biol; 2012; 826():163-75. PubMed ID: 22167648
[TBL] [Abstract][Full Text] [Related]
27. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
Ma XL; Sun YF; Wang BL; Shen MN; Zhou Y; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Guo W; Yang XR
BMC Cancer; 2019 Aug; 19(1):760. PubMed ID: 31370822
[TBL] [Abstract][Full Text] [Related]
28. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma.
Yamamoto Y; Kosaka N; Tanaka M; Koizumi F; Kanai Y; Mizutani T; Murakami Y; Kuroda M; Miyajima A; Kato T; Ochiya T
Biomarkers; 2009 Nov; 14(7):529-38. PubMed ID: 19863192
[TBL] [Abstract][Full Text] [Related]
30. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3.
Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG
Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618
[TBL] [Abstract][Full Text] [Related]
31. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma.
Ji J; Zheng X; Forgues M; Yamashita T; Wauthier EL; Reid LM; Wen X; Song Y; Wei JS; Khan J; Thorgeirsson SS; Wang XW
Hepatology; 2015 Sep; 62(3):829-40. PubMed ID: 25953724
[TBL] [Abstract][Full Text] [Related]
32. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
33. Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
Chen Y; Zhao J; Luo Y; Wang Y; Jiang Y
Oncol Rep; 2016 Nov; 36(5):2587-2600. PubMed ID: 27573045
[TBL] [Abstract][Full Text] [Related]
34. miRNAs expressed differently in cancer stem cells and cancer cells of human gastric cancer cell line MKN-45.
Golestaneh AF; Atashi A; Langroudi L; Shafiee A; Ghaemi N; Soleimani M
Cell Biochem Funct; 2012 Jul; 30(5):411-8. PubMed ID: 22374783
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs involved in neoplastic transformation of liver cancer stem cells.
Li R; Qian N; Tao K; You N; Wang X; Dou K
J Exp Clin Cancer Res; 2010 Dec; 29(1):169. PubMed ID: 21176238
[TBL] [Abstract][Full Text] [Related]
36. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
[TBL] [Abstract][Full Text] [Related]
37. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
38. Identification of typical miRNAs and target genes in hepatocellular carcinoma by DNA microarray technique.
He TL; Zheng KL; Li G; Song B; Zhang YJ
Eur Rev Med Pharmacol Sci; 2014; 18(1):108-16. PubMed ID: 24452951
[TBL] [Abstract][Full Text] [Related]
39. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
